You are here
Pfizer's Anacor deal showcases new wave of eczema therapies
PFIZER Inc's purchase of Anacor Pharmaceuticals Inc heralds an approaching wave of potentially safer and more effective treatments for millions who suffer from eczema, a common skin condition which causes infection-prone rashes that can feel like having poison ivy 24 hours a day.
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org